Staying warm and healthy during the winter can be challenging for anyone in most parts of the country, but it can be especially difficult for cancer patients, particularly those who may be experiencing treatment-related neuropathy. Peripheral neuropathy is a temporary or long-lasting nerve problem that may occur as a result of certain chemotherapy drugs. It can cause pain, numbness, tingling, or loss of feeling, usually in the hands or feet, making snowy weather and freezing temperatures all the more challenging.
For about 70 years, the standard treatment for patients with advanced prostate cancer was drugs that blocked male hormones feeding the tumor. If that stopped working and the disease progressed, oncologists turned to chemotherapy to kill the cancer cells. This timetable is about to change. Results of a clinical trial led by a Dana-Farber researcher revealed that such patients lived longer if started on both a hormone blocker and a chemotherapy drug at the same time. The government-sponsored trial found that 69 percent of men receiving both treatments were alive at three years, compared with 52.5 percent of men who …
Dana-Farber Cancer Institute’s Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH recently partnered with CancerConnect to answer questions about breast cancer therapies. Burstein and Mayer are breast oncologists in the Center for Breast Oncology at Dana-Farber’s Susan F. Smith Center for Women’s Cancers. Q: What medications are helpful for depression after breast cancer treatment and while taking tamoxifen?
Approximately 10,000-11,000 women in the U.S. are diagnosed with cervical cancer every year. But with women having regular cervical cancer screenings, incidence and death rates from the disease have decreased by at least 80 percent in the U.S. “Cervical cancer in the U.S. has become less of a frequently diagnosed cancer because of the institution of the Pap smear,” says Ursula Matulonis, MD, medical director of Gynecologic Oncology at the Susan F. Smith Center for Women’s Cancers at Dana-Farber. As January marks Cervical Cancer Awareness Month, here are five important questions about cervical cancer screening:
Ann LaCasce, MD, a medical oncologist in the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, answered a variety of questions about Hodgkin and non-Hodgkin lymphoma during a live web chat hosted by Dana-Farber last month.
Whether you’re trying to lose weight, gain weight, or just stay healthy, the New Year always brings a new set of goals and resolutions. While this change in lifestyle can often feel daunting, achieving goals does not have to be a solo mission. “Let friends, family members and co-workers know what your goal is and what you are trying to do,” says Nancy Campbell, MS, exercise physiologist with Dana-Farber Cancer Institute. “Having these people around can give you the support you need to reach that goal.” As you work out healthy goals for 2014, consider these five tips from Campbell …
Experts with the U.S. Preventive Services Task Force (USPSTF) have recommended that current smokers and former-smokers who recently quit should undergo an annual low-dose CT scan to screen for lung cancer.
As 2013 comes to a close, we’re looking back at some of our favorite Insight posts from the last year. From inspiring patient stories to important research, here is our top 10 list: